Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 2010Health Technology AssessmentOpen Access

Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation

View Full Paper
Ask AI
Bookmark
Share

Authors

NWN WaughUniversity of AberdeenECE CumminsLantiq (Germany)PRPamela RoyleUniversity of Aberdeen

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Waugh et al. (2010) studied this question.

synapsesocial.com/papers/6a8cdf3d3666819b0c3019fahttps://doi.org/10.3310/hta14360
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Starting Insulin Therapy in Patients With Type 2 Diabetes1997 · 203 citations
  2. 2Effects of Metformin in Patients with Poorly Controlled, Insulin-Treated Type 2 Diabetes Mellitus1999 · 225 citations
  3. 3Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes2005 · 220 citations
  4. 4Once-daily sitagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of patients with type 2 diabetes2007 · 160 citations
  5. 5Frequency and predictors of hypoglycaemia in Type 1 and insulin‐treated Type 2 diabetes: a population‐based study2005 · 515 citations